Ceres Licenses DNA Browser Software to Bayer CropScience

           Ceres Licenses DNA Browser Software to Bayer CropScience

- Company will pursue additional enterprise-grade installations among life
science companies

- Software as a Service option planned for broader research community

PR Newswire

THOUSAND OAKS, Calif., July 8, 2014

THOUSAND OAKS, Calif., July 8, 2014 /PRNewswire/ -- Ceres, Inc. (NASDAQ:
CERE), an agricultural biotechnology and seed company, today announced that
the company has licensed its Persephone genome visualization application to
Bayer CropScience. The multi-year software license and collaboration agreement
provides a non-exclusive license to Bayer as well as professional services
including support, customizations and maintenance. Bayer is the second
multi-national life sciences company to license Persephone as its primary
genome browser.

Originally developed for in-house use by Ceres, Persephone allows researchers
to rapidly zoom in and out of massive amounts of genetic data, from a
chromosome level to a single building block of DNA. On top of this data, users
can layer and cross reference related information in much the same way
geographic mapping services allow users to add weather information or business
locations to a geographic map.

"We are proud to have Bayer select Persephone as its primary genome browser
for its in-house R&D, and we look forward to working with Bayer for many years
to come," said Richard Hamilton, President and CEO of Ceres. "The explosion of
low cost full genome DNA sequencing, from plant science to biomedical
research, is creating incredibly large data sets that are rich sources of
information if mined effectively. Persephone provides us with a significant
near-term opportunity to leverage our expertise in bioinformatics and genetic
analysis, while accelerating our own internal research and development work,"
Hamilton said.

Dr. Jakob de Vlieg, Head of the Computational Life Sciences group at Bayer
CropScience said, "Our company will benefit from implementing this integrated
solution, as this platform is allowing interactive querying and integrated
visualization of various omics data. The Persephone genome browser impressed
both our geneticists and bioinformaticians with its performance and user
friendly interface. Persephone will allow them to make decisions on
experimental approaches."

Tim Swaller, Ceres' Vice President of Genomics Technologies, noted that speed
is taken for granted across most software markets, but the genetics market has
struggled with massive datasets generated by DNA sequencing and genetic
testing. For instance, a typical genome contains multiple terabytes of data.
Plant genomes, which can be larger than the human genome, have been some of
the most challenging.

To help solve the speed problem, and expand the way researchers can explore
and mine genetic data, Persephone software engineers have developed a number
of proprietary data-compression methods and other optimizations. "The speed
itself changes the way researchers can use their data. It encourages more
exploratory research and better utilization of genetic data," said Swaller.
Ceres has used Persephone in its marker-assisted breeding and biotech trait
pipelines to speed the development of elite parental breeding lines and
improved sorghum hybrids for Brazil.

Swaller said that Persephone can be deployed across a number of life science
technology platforms that utilize genetic data. Ceres currently offers
Persephone as a client-server installation and is developing a Software as a
Service (SaaS) model that is intended to provide individual researchers with
an online tool to visualize and compare genetic information stored in public
databases. The company has targeted the deployment of a cloud-based beta
version of Persephone by the end of this year.

"We believe there is a large number of individual researchers currently that
could benefit from the Persephone interface," Swaller said. He noted that
Ceres is also exploring opportunities for the software outside of the plant
sciences.

About Persephone
Persephone is a genome visualization application marketed by Ceres, Inc. The
software allows researchers to explore DNA databases in much the same way
online mapping programs allow users toexplore geographic regions and places.
Persephone has been designedto display diverse data such as genetic maps,
genomic sequences, gene models, synteny,QTLs, SNPs, RNA-Seq, and gene
expression, among others. The software features an ultra-fast
graphics-rendering engine that can load and visualize 30 million SNPs in 30
seconds in client-server installations. Persephone is a trademark of Ceres,
Inc.

About Ceres
Ceres, Inc. is an agricultural biotechnology company that markets seeds for
energy crops used in the production of renewable transportation fuels,
electricity and bio-based products. The company also licenses its genetics
technology, software and biotech traits to other organizations.

Ceres Forward-Looking Statements
This press release may contain forward-looking statements. All statements,
other than statements of historical facts, including statements regarding
Ceres' efforts to develop and commercialize its products, anticipated yields
and product performance, status of crop plantings, short-term and long-term
business strategies, market and industry expectations, future operating
metrics, and future results of operations and financial position, including
anticipated cost savings from our plan to align expenditures, are
forward-looking statements. You should not place undue reliance on these
forward-looking statements because they involve known and unknown risks,
uncertainties and other factors that are, in some cases, beyond Ceres'
control. Factors that could materially affect actual results can be found in
Ceres' filings with the U.S. Securities and Exchange Commission. Ceres
undertakes no obligation to update publicly, except to the extent required by
law, any forward-looking statements for any reason after the date the company
issues this press release to conform these statements to actual results or to
changes in the company's expectations.

SOURCE Ceres, Inc.

Website: http://www.ceres.net
Contact: Ceres, Inc., Gary Koppenjan, (805) 376-6546, mediaoffice@ceres.net
 
Press spacebar to pause and continue. Press esc to stop.